Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease
Open Access
- 17 November 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 1045168
Abstract
Hematopoietic allogeneic stem cell transplantation (allo-SCT) is a curative option for patients with hematological malignancies. However, due to disparities in major and minor histocompatibility antigens between donor and recipient, severe inflammatory complications can occur, among which chronic graft-versus-host disease (cGVHD) can be life-threatening. A classical therapeutic approach to the prevention and treatment of cGVHD has been broad immunosuppression, but more recently adjuvant immunotherapies have been tested. This review summarizes and discusses immunomodulatory approaches with T cells, including chimeric antigen receptor (CAR) and regulatory T cells, with natural killer (NK) cells and innate lymphoid cells (ILCs), and finally with mesenchymal stromal cells (MSC) and extracellular vesicles thereof. Clinical studies and pre-clinical research results are presented likewise.Keywords
This publication has 165 references indexed in Scilit:
- Circulating Mesenchymal Stem Cells Microparticles in Patients with Cerebrovascular DiseasePLOS ONE, 2012
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliteransBlood, 2012
- Mesenchymal Stem Cells Induce Functionally Active T-Regulatory Lymphocytes in a Paracrine Fashion and Ameliorate Experimental Autoimmune UveitisInvestigative Ophthalmology & Visual Science, 2012
- Peripheral education of the immune system by colonic commensal microbiotaNature, 2011
- Massive ex Vivo Expansion of Human Natural Regulatory T Cells (T regs ) with Minimal Loss of in Vivo Functional ActivityScience Translational Medicine, 2011
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kineticsBlood, 2011
- Mesenchymal stem cell as salvage treatment for refractory chronic GVHDBone Marrow Transplantation, 2010
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantationJournal of Clinical Investigation, 2010
- Graft-versus-host diseaseThe Lancet, 2009
- Host natural killer T cells induce an interleukin-4–dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host diseaseBlood, 2009